Humacyte, Inc. (NASDAQ:HUMAW – Get Rating) was the recipient of a large increase in short interest during the month of February. As of February 28th, there was short interest totalling 4,900 shares, an increase of 6.5% from the February 13th total of 4,600 shares. Based on an average daily volume of 11,000 shares, the days-to-cover ratio is presently 0.4 days.

Institutional Trading of Humacyte

An institutional investor recently raised its position in Humacyte stock. LPL Financial LLC increased its stake in Humacyte, Inc. (NASDAQ:HUMAW – Get Rating) by 15.5% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 223,656 shares of the company's stock after acquiring an additional 30,000 shares during the quarter. LPL Financial LLC's holdings in Humacyte were worth $88,000 at the end of the most recent reporting period.

Humacyte Price Performance

Humacyte stock opened at $0.67 on Friday. Humacyte has a 52-week low of $0.38 and a 52-week high of $2.38. The stock's 50 day moving average price is $0.60.

Further Reading

• Get a free copy of the StockNews.com research report on Humacyte (HUMAW)
• This Small Tech With Big Growth Prospects Is Nearing A Buy Point
• Don't Chase FedEx Higher, Wait For The Pullback
• 3 Stocks For A Defensive Tech Portfolio
• Milk the Dividends on These 3 Cash Cows
• Europe Raises Interest Rates, Should the Fed Follow?

Receive News & Ratings for Humacyte Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humacyte and related companies with MarketBeat.com's FREE daily email newsletter.